Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Gregson

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Emerging Infectious Diseases|June 8, 2007
Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, CalgaryJohann D D Pitout, Daniel B Gregson, Deirdre L Church, et al.
Journal of Clinical Microbiology|December 14, 2011
Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian regionGisele Peirano, Akke K van der Bij, Daniel B Gregson, et al.
Human Pathology|November 30, 2010
Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infectionSuchin Worawichawong, Louis Girard, Kiril Trpkov, et al.
The Pediatric Infectious Disease Journal|January 1, 2009
The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000-2006Kevin B Laupland, Daniel B Gregson, Otto G Vanderkooi, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 25, 2007
Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistanceKevin B Laupland, Terry Ross, Johann D D Pitout, et al.
International Journal of Antimicrobial Agents|August 15, 2008
Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactamJohann D D Pitout, Phillip Le, Deirdre L Church, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2009
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health RegionJohann D D Pitout, Lorraine Campbell, Deirdre L Church, et al.
American Journal of Clinical Pathology|January 11, 2003
Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrheaViki Massey, Daniel B Gregson, Abdul H Chagla, et al.
Journal of Clinical Microbiology|June 16, 2005
Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health regionJohann D D Pitout, Daniel B Gregson, Deirdre L Church, et al.
BMC Infectious Diseases|April 11, 2012
The distinct category of healthcare associated bloodstream infectionsRyan Lenz, Jenine R Leal, Deirdre L Church, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Emerging Infectious Diseases|June 8, 2007
Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, CalgaryJohann D D Pitout, Daniel B Gregson, Deirdre L Church, et al.
Journal of Clinical Microbiology|December 14, 2011
Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian regionGisele Peirano, Akke K van der Bij, Daniel B Gregson, et al.
Human Pathology|November 30, 2010
Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infectionSuchin Worawichawong, Louis Girard, Kiril Trpkov, et al.
The Pediatric Infectious Disease Journal|January 1, 2009
The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000-2006Kevin B Laupland, Daniel B Gregson, Otto G Vanderkooi, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 25, 2007
Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistanceKevin B Laupland, Terry Ross, Johann D D Pitout, et al.
International Journal of Antimicrobial Agents|August 15, 2008
Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactamJohann D D Pitout, Phillip Le, Deirdre L Church, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2009
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health RegionJohann D D Pitout, Lorraine Campbell, Deirdre L Church, et al.
American Journal of Clinical Pathology|January 11, 2003
Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrheaViki Massey, Daniel B Gregson, Abdul H Chagla, et al.
Journal of Clinical Microbiology|June 16, 2005
Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health regionJohann D D Pitout, Daniel B Gregson, Deirdre L Church, et al.
BMC Infectious Diseases|April 11, 2012
The distinct category of healthcare associated bloodstream infectionsRyan Lenz, Jenine R Leal, Deirdre L Church, et al.
Pageof 8